The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 05, 2016
Filed:
Dec. 16, 2011
Osamu Sakurai, Osaka, JP;
Kunio Saruta, Osaka, JP;
Norimitsu Hayashi, Osaka, JP;
Takashi Goi, Osaka, JP;
Kenji Morokuma, Osaka, JP;
Hidekazu Tsujishima, Osaka, JP;
Hiroaki Sawamoto, Osaka, JP;
Hiroaki Shitama, Osaka, JP;
Ritsuo Imashiro, Osaka, JP;
Osamu Sakurai, Osaka, JP;
Kunio Saruta, Osaka, JP;
Norimitsu Hayashi, Osaka, JP;
Takashi Goi, Osaka, JP;
Kenji Morokuma, Osaka, JP;
Hidekazu Tsujishima, Osaka, JP;
Hiroaki Sawamoto, Osaka, JP;
Hiroaki Shitama, Osaka, JP;
Ritsuo Imashiro, Osaka, JP;
MITSUBISHI TANABE PHARMA CORPORATION, Osaka-shi, JP;
Abstract
This is to provide a continuous arycyclic compound having a DGAT1 inhibitory activity, and useful for prophylaxis and/or treatment of obesity or hyperlipidemia caused by obesity, hypertriglyceridemia, lipid metabolism disorder, fatty liver, hypertension, arteriosclerosis, diabetes, etc., as well as to provide a DGAT1 inhibitor comprising the continuous arycyclic compound or a pharmaceutically acceptable salt thereof as an effective ingredient. Disclosed is the continuous arycyclic compound is represented by the formula: wherein the substituents in the formula are the same as defined in the specification, or a pharmaceutically acceptable salt thereof.